Literature DB >> 21352848

Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior.

Martin J Acerbo1, Alan Kim Johnson.   

Abstract

Behavioral sensitization involves increases in the magnitude of a response to a stimulus after repeated exposures to the same response initiator. Administration of psychomotor stimulants and the induction of appetitive motivational states associated with natural reinforcers like sugar and salt are among experimental manipulations producing behavioral sensitization. In rats, repeated administration of the mineralocorticoid agonist deoxycorticosterone acetate (DOCA) initially induces incremental increases in daily hypertonic saline consumption (i.e., sensitization of sodium appetite) in spite of the retention of sodium. The present studies investigated whether sodium appetite sensitization induced by DOCA shares mechanisms similar to those of psychomotor stimulant-induced sensitization, and whether there is evidence for reciprocal cross-sensitization. In Experiments 1 and 3, rats received control or cocaine treatments to induce locomotor sensitization. A week later DOCA (or vehicle) was administered to generate a sodium appetite. Animals pretreated with cocaine showed a greater sodium appetite. In Experiment 2, the order of the putative sensitizing treatments was reversed. Rats first received either a series of DOCA or vehicle treatments either with or without access to saline and were later tested for sensitization of the locomotor response to cocaine. Animals pretreated with DOCA without access to saline showed greater locomotor responses to cocaine than animals receiving vehicle treatments. Together these experiments indicate that treatments generating a sustained salt appetite and producing cocaine-induced psychomotor responses show reciprocal behavioral cross-sensitization. The underlying mechanisms accounting for this relationship may be the fact that psychostimulants and an unresolved craving for sodium can act as potent stressors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352848      PMCID: PMC3086042          DOI: 10.1016/j.pbb.2011.02.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  86 in total

1.  Sexual experience sensitizes mating-related nucleus accumbens dopamine responses of female Syrian hamsters.

Authors:  J G Kohlert; R L Meisel
Journal:  Behav Brain Res       Date:  1999-02-15       Impact factor: 3.332

2.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

3.  EFFECT OF DEOXYCORTICOSTERONE ON SODIUM APPETITE OF INTACT AND ADRENALECTOMIZED RATS.

Authors:  G WOLF
Journal:  Am J Physiol       Date:  1965-06

4.  The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia.

Authors:  Angela J Grippo; Terry G Beltz; Robert M Weiss; Alan Kim Johnson
Journal:  Biol Psychiatry       Date:  2005-09-09       Impact factor: 13.382

5.  Regulation of chronic stress-induced changes in hypothalamic-pituitary-adrenal activity by the basolateral amygdala.

Authors:  Seema Bhatnagar; Courtenay Vining; Kai Denski
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 6.  Physiology and neurobiology of stress and adaptation: central role of the brain.

Authors:  Bruce S McEwen
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

7.  A comparison of two behavioral measures of psychomotor activation following intravenous amphetamine or cocaine: dose- and sensitization-dependent changes.

Authors:  H S Crombag; H Mueller; K E Browman; A Badiani; T E Robinson
Journal:  Behav Pharmacol       Date:  1999-03       Impact factor: 2.293

8.  Involvement of mesolimbic structures in short-term sodium depletion: in situ hybridization and ligand-binding analyses.

Authors:  Louis R Lucas; Claudia A Grillo; Bruce S McEwen
Journal:  Neuroendocrinology       Date:  2003-06       Impact factor: 4.914

Review 9.  Central osmotic regulation of sympathetic nerve activity.

Authors:  G M Toney; Q H Chen; M J Cato; S D Stocker
Journal:  Acta Physiol Scand       Date:  2003-01

Review 10.  A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.

Authors:  S D Robertson; H J G Matthies; A Galli
Journal:  Mol Neurobiol       Date:  2009-02-06       Impact factor: 5.590

View more
  6 in total

1.  High-Salt Exposure During Perinatal Development Enhances Stress Sensitivity.

Authors:  Paige M Dingess; Amit Thakar; Zhaojie Zhang; Francis W Flynn; Travis E Brown
Journal:  Dev Neurobiol       Date:  2018-08-29       Impact factor: 3.964

2.  Properly timed exposure to central ANG II prevents behavioral sensitization and changes in angiotensin receptor expression.

Authors:  Jessica Santollo; Philip E Whalen; Robert C Speth; Stewart D Clark; Derek Daniels
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-10-29       Impact factor: 3.619

3.  Activation of the renin-angiotensin system, specifically in the subfornical organ is sufficient to induce fluid intake.

Authors:  Jeffrey P Coble; Martin D Cassell; Deborah R Davis; Justin L Grobe; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-25       Impact factor: 3.619

4.  Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice.

Authors:  Toyoshi Umezu
Journal:  ISRN Pharmacol       Date:  2012-03-20

Review 5.  From passive overeating to "food addiction": a spectrum of compulsion and severity.

Authors:  Caroline Davis
Journal:  ISRN Obes       Date:  2013-05-15

6.  Angiotensin II AT₁ receptors are involved in neuronal activation induced by amphetamine in a two-injection protocol.

Authors:  Maria Constanza Paz; Natalia Andrea Marchese; Liliana M Cancela; Claudia Bregonzio
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.